معرفی
Corinna Sorenson serves as an Assistant Professor in Population Health Sciences and the Sanford School of Public Policy at Duke University. She holds dual appointments reflecting her interdisciplinary work at the intersection of health policy, economics, and clinical practice, with additional roles as Core Faculty Member at the Duke-Margolis Institute for Health Policy and Associate of the Duke Initiative for Science & Society.
Education
- Ph.D., London School of Economics (United Kingdom), 2015
Research Interests
Dr. Sorenson's research program centers on value assessment in health care, comparative effectiveness research, drug and device regulation, and health policy evaluation. She investigates the economic, methodological, political, cultural, organizational, professional, and legal levers that influence adoption of value-based health care strategies for new and existing treatments. Her work spans the design, implementation, and assessment of innovative evidence-based approaches to enhance health care value across diverse clinical contexts. She also develops educational frameworks in health policy and management as Faculty Director of Graduate Education Initiatives.
Publication Trends
Analysis of Dr. Sorenson's recent publications (2014-2023) reveals three dominant thematic clusters: low-value care reduction strategies across neurology, oncology, and geriatrics; value-based payment reform with emphasis on health equity; and international comparative studies of health technology assessment systems. Her work consistently applies health economics frameworks to address real-world implementation challenges, with growing focus on policy responses to the COVID-19 pandemic and emerging biotechnologies.
Scientific Awards
No scientific awards or major honors are documented in the provided information.
Advising and Grants
As Faculty Director of the Margolis Scholars in Health Policy and Management Program, Dr. Sorenson oversees graduate training initiatives. Her substantial research portfolio includes:
- Implementing the Inflation Reduction Act: Proposal to Address Key Issues for Advancing Pharmaceutical Innovation, Access, Affordability, and Impact (2024-2026)
- Medicaid Best Price and the Medicaid Drug Rebate Program in the Context of Cell and Gene Therapies (2025-2026)
- NC Medicaid Value-Based Payment Implementation (2022-2026)
- Accelerating Value-Based Care Impact at the State and National Level (2020-2023)
- Informing Policy Options to Integrate Care for Dual Eligible North Carolinians (2021-2022)
- Cardiovascular Risk Profile of LAL Deficiency Patients (2016-2020)
- Exploring Value-Based Care from Various Perspectives (2018-2019)
- Exploring the Evidence on the Potential Impact of Reducing Areas of Low-Value Care (2018-2019)
- Challenges to Reducing Low-Value Care: Lessons Learned and Future Directions (2017-2018)
Labs and Teams
Dr. Sorenson's primary research ecosystems include the Duke-Margolis Institute for Health Policy, where she contributes to evidence generation for health care innovation and regulation, and the Duke Initiative for Science & Society, which facilitates cross-disciplinary dialogue on science policy. These platforms enable collaborations with policymakers, industry stakeholders, and clinicians to translate research into practical health system improvements.
